Biotechnology Headlines from PR Newswire

< Go Back

Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
NeuroDerm Secures $16 Million Financing Round
Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk
Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity
Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth
Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify
Three Leading Academic Medical Centers Join Bone Health Collaborative to Implement the Fracture Liaison Service Care Coordination Project
OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution
China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results
Clintrax Global, Inc. Announces Addition to Executive Team
AlloSource® Announces Milo Metcalf As Vice President Of Operations
PTC Therapeutics to Participate at Upcoming Investor Conferences
Neurotrope To Host Conference Call
Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023
PAREXEL International To Present At Baird Healthcare Conference
BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market
Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark
Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research
Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents
KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema
Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies
Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders English
Global Cell and Tissue Culture Supplies - Strategic Business Report 2014
Geisinger investigator nominated for federal award
Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019
Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014
New England Biolabs® Introduces New Ribosomal RNA Depletion Technology from Genomic Health
CVac™ CAN-003 Abstract Accepted For Poster Presentation At The Society For Immunotherapy Of Cancer Annual Meeting
CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board
Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014
Quality and Compliance Solutions Provider Announces Opening of St. Louis, Missouri Office
Oramed Granted Patent in Spain for Oral Administration of Insulin
Cellular Research Launches Early Access Program for Precise™ Assays
Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting
iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC
Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market
Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live
SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost
Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc.
Bioseparation Systems for Global Biopharmaceutical Markets
PDL BioPharma Announces Second Quarter 2014 and Year to Date Financial Results English
Pharmacyclics Appoints Chief Commercial Officer
Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research
Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 English
AbbVie Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Annual Academic Awards

< Prev Next >
PR Newswire - United Business Media